Argenx
ARGX
#456
Rank
A$75.38 B
Marketcap
A$1,218
Share price
-0.10%
Change (1 day)
16.91%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2025 : A$8.72 Billion

According to Argenx 's latest financial reports the company has A$8.72 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2019 to 2020)

Net assets by year

Year Net assets Change
2024-12-31$A$8.83 B46.98%
2023-12-31$A$6.01 B45.46%
2022-12-31$A$4.13 B18.28%
2021-12-31$A$3.49 B60.56%
2020-12-31$A$2.17 B29.13%
2019-12-31$A$1.68 B68.58%
2018-12-31$A$1.00 B57.25%
2017-12-31$A$0.63 B553.91%
2016-12-31$A$97.25 M58.99%
2015-12-31$A$61.17 M-32.41%
2014-12-31$A$90.5 M95.03%
2013-12-31$A$46.4 M118.93%
2012-12-31$A$21.19 M-40.02%
2011-12-31$A$35.33 M163.71%
2010-12-31$A$13.39 M